| molecular function |
|---|
| | GO:0003677 | | DNA binding | | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| | GO:0000981 | | RNA polymerase II transcription factor activity, sequence-specific DNA binding | | Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
| | GO:0008013 | | beta-catenin binding | | Interacting selectively and non-covalently with the beta subunit of the catenin complex. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0046982 | | protein heterodimerization activity | | Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. |
| | GO:0043565 | | sequence-specific DNA binding | | Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
| | GO:0003713 | | transcription coactivator activity | | Interacting selectively and non-covalently with a activating transcription factor and also with the basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. |
| | GO:0003705 | | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding | | Interacting selectively and non-covalently with a sequence of DNA that is in a distal enhancer region for RNA polymerase II (RNAP II) in order to modulate transcription by RNAP II. |
| | GO:0003700 | | transcription factor activity, sequence-specific DNA binding | | Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
| | GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| | GO:0044212 | | transcription regulatory region DNA binding | | Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
| | GO:0001228 | | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding | | Interacting selectively and non-covalently with a sequence of DNA that is in the transcription regulatory region for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
| biological process |
|---|
| | GO:0016055 | | Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
| | GO:0001525 | | angiogenesis | | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| | GO:0060070 | | canonical Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. |
| | GO:0060913 | | cardiac cell fate determination | | The process involved in cardiac cell fate commitment. Once determination has taken place, a cell becomes committed to differentiate down a particular pathway regardless of its environment. |
| | GO:0003142 | | cardiogenic plate morphogenesis | | The process in which the anatomical structures of the cardiogenic plate are generated and organized. The cardiogenic plate is the first recognizable structure derived from the heart field. |
| | GO:0042074 | | cell migration involved in gastrulation | | The migration of individual cells within the blastocyst to help establish the multi-layered body plan of the organism (gastrulation). For example, the migration of cells from the surface to the interior of the embryo (ingression). |
| | GO:0061009 | | common bile duct development | | The progression of the common bile duct over time, from its formation to the mature structure. The common bile duct is formed from the joining of the common hepatic duct running from the liver, and the cystic duct running from the gall bladder. The common bile duct transports bile from the liver and gall bladder to the intestine. |
| | GO:0048617 | | embryonic foregut morphogenesis | | The process in which the anatomical structures of the foregut are generated and organized, during the embryonic phase. |
| | GO:0035050 | | embryonic heart tube development | | The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field. |
| | GO:0003143 | | embryonic heart tube morphogenesis | | The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart. |
| | GO:0048568 | | embryonic organ development | | Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
| | GO:0060956 | | endocardial cell differentiation | | The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of an endocardial cell. An endocardial cell is a specialized endothelial cell that makes up the endocardium portion of the heart. The endocardium is the innermost layer of tissue of the heart, and lines the heart chambers. |
| | GO:0060214 | | endocardium formation | | Formation of the endocardium of the heart. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers. |
| | GO:0007492 | | endoderm development | | The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues. |
| | GO:0001706 | | endoderm formation | | The formation of the endoderm during gastrulation. |
| | GO:0007493 | | endodermal cell fate determination | | The cell fate determination process in which a cell becomes capable of differentiating autonomously into an endoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed. |
| | GO:0061031 | | endodermal digestive tract morphogenesis | | The process in which the anatomical structures of the endodermal digestive tract are generated and organized. The endodermal digestive tract includes those portions of the digestive tract that are derived from endoderm. |
| | GO:0061010 | | gall bladder development | | The progression of the gall bladder over time, from its initial formation to the mature structure. The gall bladder is a cavitated organ that stores bile. |
| | GO:0007369 | | gastrulation | | A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm. |
| | GO:0001947 | | heart looping | | The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation. |
| | GO:0001828 | | inner cell mass cellular morphogenesis | | The morphogenesis of cells in the inner cell mass. |
| | GO:0042789 | | mRNA transcription from RNA polymerase II promoter | | The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. |
| | GO:0030178 | | negative regulation of Wnt signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway. |
| | GO:0003308 | | negative regulation of Wnt signaling pathway involved in heart development | | Any process that decreases the rate, frequency, or extent of the series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell, resulting a change in cell state that contributes to the progression of the heart over time. |
| | GO:0090090 | | negative regulation of canonical Wnt signaling pathway | | Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
| | GO:0030308 | | negative regulation of cell growth | | Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
| | GO:0042662 | | negative regulation of mesodermal cell fate specification | | Any process that stops, prevents, or reduces the frequency, rate or extent of mesoderm cell fate specification. |
| | GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0003151 | | outflow tract morphogenesis | | The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. |
| | GO:0045597 | | positive regulation of cell differentiation | | Any process that activates or increases the frequency, rate or extent of cell differentiation. |
| | GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:0045732 | | positive regulation of protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. |
| | GO:0048643 | | positive regulation of skeletal muscle tissue development | | Any process that activates, maintains or increases the rate of skeletal muscle tissue development. |
| | GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0031648 | | protein destabilization | | Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation. |
| | GO:0050821 | | protein stabilization | | Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. |
| | GO:2000043 | | regulation of cardiac cell fate specification | | Any process that modulates the frequency, rate or extent of cardiac cell fate specification. |
| | GO:0045595 | | regulation of cell differentiation | | Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features. |
| | GO:0045995 | | regulation of embryonic development | | Any process that modulates the frequency, rate or extent of embryonic development. |
| | GO:0042661 | | regulation of mesodermal cell fate specification | | Any process that modulates the frequency, rate or extent of mesoderm cell fate specification. |
| | GO:2000035 | | regulation of stem cell division | | Any process that modulates the frequency, rate or extent of stem cell division. |
| | GO:0072091 | | regulation of stem cell proliferation | | Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells. |
| | GO:0060807 | | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | | Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter that ultimately results in a cell being specified to adopt a definitive endodermal cell fate. |
| | GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0072001 | | renal system development | | The process whose specific outcome is the progression of the renal system over time, from its formation to the mature structure. The renal system maintains fluid balance and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels. |
| | GO:0021903 | | rostrocaudal neural tube patterning | | The process in which the neural tube is divided into specific regions along the rostrocaudal axis. |
| | GO:0023019 | | signal transduction involved in regulation of gene expression | | Any process that modulates the frequency, rate or extent of gene expression as a consequence of a process in which a signal is released and/or conveyed from one location to another. |
| | GO:0007283 | | spermatogenesis | | The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis. |
| | GO:0048863 | | stem cell differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells. |
| | GO:0048866 | | stem cell fate specification | | The process in which a cell becomes capable of differentiating autonomously into a stem cell in an environment that is neutral with respect to the developmental pathway. Upon specification, the cell fate can be reversed. |
| | GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
| | GO:0001570 | | vasculogenesis | | The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes. |
| cellular component |
|---|
| | GO:0044798 | | nuclear transcription factor complex | | A protein complex, located in the nucleus, that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0005667 | | transcription factor complex | | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
Description
